Several classes of drug products have been used since the launch of statins to treat hypercholesterolemia in humans and many of these approaches of cholesterol lowering involve inducing LDL receptor activity (Table 1, Figure 2). The gene discussed is LDLR; the disease is familial hypercholesterolemia.